Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Agile Therapeutics (AGRX)
NASDAQ:AGRX
Agile Therapeutics (AGRX) Financial Statements
1,459 Followers
Agile Therapeutics Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 3.00M | $ 2.13M | $ 1.76M | $ 1.51M | $ 1.29M |
| Gross Profit | $ 1.58M | $ -105.00K | $ 234.00K | $ -4.19M | $ -1.42M |
| EBIT | $ -18.66M | $ -11.40M | $ -15.57M | $ -22.36M | $ -15.77M |
| EBITDA | $ -18.40M | $ -10.80M | $ -14.98M | $ -21.78M | $ -15.22M |
| Net Income Common Stockholders | $ -19.67M | $ -12.22M | $ -11.77M | $ -23.36M | $ -16.77M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 6.14M | $ 13.03M | $ 3.74M | $ 19.14M | $ 14.73M |
| Total Assets | $ 18.46M | $ 32.83M | $ 29.30M | $ 39.33M | $ 36.68M |
| Total Debt | $ 2.15M | $ 13.50M | $ 13.19M | $ 17.79M | $ 16.47M |
| Net Debt | $ -4.00M | $ 472.00K | $ 9.45M | $ -1.35M | $ 1.74M |
| Total Liabilities | $ 12.20M | $ 29.41M | $ 26.56M | $ 30.06M | $ 26.00M |
| Stockholders Equity | $ 6.26M | $ 3.42M | $ 2.74M | $ 9.27M | $ 10.68M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -16.70M | $ -2.94M | $ -14.88M | $ -16.67M | $ -18.64M |
| Operating Cash Flow | $ -16.70M | $ -2.93M | $ -14.75M | $ -16.62M | $ -18.58M |
| Investing Cash Flow | $ 0.00 | $ -7.00K | $ -126.00K | $ -55.00K | $ 4.93M |
| Financing Cash Flow | $ 9.82M | $ 12.22M | $ -523.00K | $ 21.08M | $ 2.26M |
Agile Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.